GuruFocus.com via Yahoo
Dynavax Technologies Corp (DVAX) Q2 2024 Earnings Call Highlights: Record HEPLISAV-B Sales and ...
Dynavax Technologies Corp (DVAX) reports a 24% increase in HEPLISAV-B revenue and advances its vaccine pipeline, while navigating rising expenses and market uncertainties.
48 minutes ago